Discover how Intradermal Drug Delivery can realise the full potential of your vaccines and therapeutics.
Enhanced Immune Responses, Fractional Dosing, Reduced Side Effects.
Enhanced Immune Responses, Improved Access to Lymph Nodes.
Increased bioavailability, faster absorption and increased Cmax, enhanced efficacy, reduced systemic A/Es
Maintain Cell Viability, Targeted Delivery, Access to Lymph Nodes.
Pharma Latch has revolutionized intradermal drug delivery, making it a simple and reliable route of administration for the first time.
We have developed a unique portfolio of healthcare professional and self-administration intradermal injection devices based on an innovative microneedle technology. Our devices allow for simple, reliable, and repeatable intradermal drug delivery, overcoming the previous challenges associated with this route of administration. This innovation enables a wide range of therapies to fully harness the proven benefits of intradermal drug delivery, unlocking their full therapeutic potential
The PL-Intradermal Delivery platform is purpose-built for the pharmaceutical industry, offering comprehensive support across your entire R&D process. From the Pharma Latch Pico, an adapted device for pre-clinical testing in small animals (rats/mice), to the Pharma Latch Hollow for HCP-administered clinical use in humans, and the Pharma Latch Self for patient self-administration, we are your partner throughout every stage of your intradermal drug delivery journey.
03/04/2025
We are thrilled to announce that Pharma Latch has been shortlisted for the following award categories at the Life Science Industry Awards 2025: Innovation of the Year: Pharma Latch – Revolutionising Intradermal Drug Delivery Medtech Excellence Award: Pharma Latch The Life Sciences Industry Awards celebrate excellence across the entire spectrum of Irish innovation, including pharmaceuticals, […]
read on31/03/2025
We are delighted to announce that we have established our manufacturing line for the Pharma Latch Hollow* at our partners FDA and ISO certified manufacturing facilities in the United States. Ronan Byrne, CEO of Pharma Latch, stated, “This is a milestone in bringing our technology to market. We are hugely excited by the impact Pharma […]
read on
